2-苯基丙酰氯 | 22414-26-2

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物 - 羧酸酰卤化物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-苯基丙酰氯
• 中文别名: 氢化阿托酰氯
• 英文名称: 2-phenylpropionyl chloride
• 英文别名: methylphenylacetyl chloride；2-phenylpropanoyl chloride
• CAS: 22414-26-2
• 化学式: C₉H₉ClO
• 分子量: 168.623
• InChiKey: FOTITZRWZUAVPH-UHFFFAOYSA-N

物化性质

• 熔点：
  112-114 °C(Solv: ligroine (8032-32-4); dichloromethane (75-09-2))
• 沸点：
  98-100 °C(Press: 15 Torr)
• 密度：
  1.139±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险品标志：
  C
• 安全说明：
  S26,S36/37/39,S45
• 危险类别码：
  R34
• WGK Germany：
  3
• 海关编码：
  2916399090
• 储存条件：
  室温

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : 2-Phenylpropionyl chloride
CAS-No. : 22414-26-2
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
Skin corrosion (Category 1B)
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Causes burns.
Label elements
Labelling according Regulation (EC) No 1272/2008 [CLP]
Pictogram
Signal word Danger
Hazard statement(s)
H314 Causes severe skin burns and eye damage.
Precautionary statement(s)
P280 Wear protective gloves/ protective clothing/ eye protection/ face
protection.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
P310 Immediately call a POISON CENTER or doctor/ physician.
Supplemental Hazard none
Statements
According to European Directive 67/548/EEC as amended.
Hazard symbol(s)
R-phrase(s)
R34 Causes burns.
S-phrase(s)
S26 In case of contact with eyes, rinse immediately with plenty of water and
seek medical advice.
S36/37/39 Wear suitable protective clothing, gloves and eye/face protection.
S45 In case of accident or if you feel unwell, seek medical advice immediately
(show the label where possible).
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Synonyms : Hydratropoyl chloride
Formula : C9H9ClO
Molecular Weight : 168,62 g/mol
Component Concentration
Hydratropoyl chloride
CAS-No. 22414-26-2 -

---

Section 4. FIRST AID MEASURES
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Take off contaminated clothing and shoes immediately. Wash off with soap and plenty of water. Consult a
physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Do NOT induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with
water. Consult a physician.
Most important symptoms and effects, both acute and delayed
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Indication of any immediate medical attention and special treatment needed
no data available

---

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, Hydrogen chloride gas
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid breathing vapors, mist or gas. Ensure adequate ventilation.
Evacuate personnel to safe areas.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Soak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid inhalation of vapour or mist.
Normal measures for preventive fire protection.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are
opened must be carefully resealed and kept upright to prevent leakage.
hygroscopic Moisture sensitive. Store under inert gas.
Specific end uses
no data available

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Tightly fitting safety goggles. Faceshield (8-inch minimum). Use equipment for eye protection
tested and approved under appropriate government standards such as NIOSH (US) or EN
166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator
with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup
to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air
respirator. Use respirators and components tested and approved under appropriate government
standards such as NIOSH (US) or CEN (EU).

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: clear
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing no data available
point
f) Initial boiling point and 80 °C at 5,33 hPa
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
Exposure to moisture.
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

---

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. Material is extremely destructive to the tissue of
the mucous membranes and upper respiratory tract.
Ingestion May be harmful if swallowed. Causes burns.
Skin May be harmful if absorbed through skin. Causes skin burns.
Eyes Causes eye burns.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Additional Information
RTECS: Not available

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

---

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: 3265 IMDG: 3265 IATA: 3265
UN proper shipping name
ADR/RID: CORROSIVE LIQUID, ACIDIC, ORGANIC, N.O.S. (Hydratropoyl chloride)
IMDG: CORROSIVE LIQUID, ACIDIC, ORGANIC, N.O.S. (Hydratropoyl chloride)
IATA: Corrosive liquid, acidic, organic, n.o.s. (Hydratropoyl chloride)
Transport hazard class(es)
ADR/RID: 8 IMDG: 8 IATA: 8
Packaging group
ADR/RID: II IMDG: II IATA: II
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

---

SECTION 15 - REGULATORY INFORMATION
N/A

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-苯基丙酰氯 在 六甲基磷酰三胺 、 sodium tetrahydroborate 、 cadmium(II) chloride 作用下， 以 乙腈 为溶剂， 反应 0.05h， 生成 2-苯基丙醛
  参考文献：
  名称：

  从苯乙醛衍生物中一锅法制备 3,5-己二烯酸化合物

  摘要：

  摘要 描述了通过立体选择性过程中的二甲基-3-甲基戊二酸和苯乙醛衍生物缩合合成 6-芳基-4-甲氧基羰基-3-甲基-3,5-己二烯酸。

  DOI：

  10.1080/00397919108019763
• 作为产物：
  描述：

  杨梅醛 在 氯化亚砜 、 permanganate(VII) ion 作用下， 生成 2-苯基丙酰氯
  参考文献：
  名称：

  酮亚胺的快速酸催化和非催化水合

  摘要：

  在pH范围为2-13的水中（μ1.0； 25°）中，已经检查了一系列酮亚胺（9）的水合速率。注意到了三种水合成酰胺的机理（8）：（a）在2-7的pH范围内，从H 3 O +进行质子转移，产生一般的酸催化作用（给出k H 3 O + / k D 3 O + 2.65）；（b）在pH＞ 7（其中k H 2 O + / k D 2 O +＝ 4.8）下由H 2 O进行的一般酸催化作用；（c）确定HO –攻击的速率。最后一种机制仅显示为N-芳基酮亚胺，例如（9e）；其他N-烷基酮亚胺继续通过速率决定质子从水的反应进行反应，即使在pH 13时也是如此。当（9a）在酸性或碱性D 2 O中反应时，仅掺入一个氘，而氘代的酮亚胺（9f ）仅掺入一个氘就证实了这一结果。）不会在水中反应时使标签松动。对于涉及从H 3 O +或H 2转移H +的反应，取代基的作用是平行的O; 在改变碳（质子化位点）上的取代基方面

  DOI：

  10.1039/p29800000579
• 作为试剂：
  描述：

  sec-butyloxycarbonylmethylene triphenyl phosphorane 在 2-苯基丙酰氯 作用下， 以 苯 为溶剂， 生成 (+-)-(sek.-Butyloxy-carbonyl-methyl)-triphenylphosphoniumchlorid
  参考文献：
  名称：

  亚烷基次膦酸酯—XVIII：Kinetische racematspaltungen durch umsetzung von亚烷基次膦酸酯

  摘要：

  亚烷基膦基膦与酰基氯的反应是通过亚烷基化进行的。从包含手性P原子和光学活性酰氯的亚烷基磷烷开始，观察到有机磷化合物的部分动力学拆分。1-碳乙氧基亚乙基萘基苯基甲基磷烷与光学活性酰氯的反应通过同时动力学拆分和部分不对称合成烯丙基羧酸酯来进行。在酯官能团中含有手性中心的碳烷氧基亚甲基-三苯基膦与光学活性酰基氯的反应中也观察到动力学拆分。在反应产物水解后获得光学活性醇。讨论了反应的空间过程，并指定了几种化合物的绝对构型。

  DOI：

  10.1016/s0040-4020(01)92629-8

文献信息

• PCl₃-mediated transesterification and aminolysis of <i>tert</i>-butyl esters via acid chloride formation
  作者：Xiaofang Wu、Lei Zhou、Fangshao Li、Jing Xiao

  DOI：10.1177/1747519820987530

  日期：2021.5

  A PCl3-mediated conversion of tert-butyl esters into esters and amides in one-pot under air is developed. This novel protocol is highlighted by the synthesis of skeletons of bioactive molecules and gram-scale reactions. Mechanistic studies revealed that this transformation involves the formation of an acid chloride in situ, which is followed by reactions with alcohols or amines to afford the desired

  在空气中一锅中开发了PCl 3介导的叔丁基酯向酯和酰胺的转化。生物活性分子骨架的合成和克级反应突显了这种新颖的方案。机理研究表明，这种转化涉及原位形成酰氯，然后与醇或胺反应以提供所需的产物。
• Catalytic asymmetric epoxidations with chiral iron porphyrins
  作者：John T. Groves、Richard S. Myers

  DOI：10.1021/ja00356a016

  日期：1983.9

  Epoxydation asymetrique d'olefines prochirales par des porphyrines de fer chirales et par des composes iodosyles

  环氧不对称 d'烯烃 prochirales par des porphyrines de fer chirales et par des composes iodosyles
• Base-promoted aromatic [3,3] sigmatropic rearrangement of N-acyl-O-arylhydroxylamine derivatives
  作者：Eiji Tayama、Kazuki Hirano

  DOI：10.1016/j.tet.2018.12.058

  日期：2019.2

  temperature generated the corresponding amide enolates. The aromatic [3,3] rearrangement of the enolates provided the desired products in moderate to good yields. A crossover experiment produced only intramolecular products and clarified that the reaction proceeds via the aromatic [3,3] sigmatropic rearrangement, not a bond-cleavage–recombination process. Our method is a formal α-arylation of amides.

  成功地证明了碱促进的N-酰基-O-芳基羟胺的芳香族[3,3]σ重排，得到α-（2-羟苯基）酰胺。由N-取代的羟胺先进行N-酰化，再由铜（I）介导的O制备底物-与硼酸芳基化。在0°C至室温下，在THF中用六甲基二硅叠氮化锂（LiHMDS）处理底物，生成相应的酰胺烯酸酯。烯醇化物的芳族[3,3]重排以中等至良好的产率提供了所需的产物。交叉实验仅产生分子内产物，并澄清了反应是通过芳香族[3,3]σ重排进行的，而不是通过键断裂-重组过程进行的。我们的方法是酰胺的形式α-芳基化。
• One-pot method for the synthesis of 1-aryl-2-aminoalkanol derivatives from the corresponding amides or nitriles
  作者：Jan Otevrel、David Svestka、Pavel Bobal

  DOI：10.1039/d0ra04359a

  日期：——

  We have identified a novel one-pot method for the synthesis of β-amino alcohols, which is based on C–H bond hydroxylation at the benzylic α-carbon atom with a subsequent nitrile or amide functional group reduction. This cascade process uses molecular oxygen as an oxidant and sodium bis(2-methoxyethoxy)aluminum hydride as a reductant. The substrate scope was examined on 30 entries and, although the

  我们已经确定了一种用于合成 β-氨基醇的新型一锅法，该方法基于苄基 α-碳原子上的 C-H 键羟基化，随后腈或酰胺官能团还原。这种级联过程使用分子氧作为氧化剂和双（2-甲氧基乙氧基）氢化铝钠作为还原剂。对 30 个条目检查了底物范围，尽管相应产品仅以中等产率提供，但上述简单方案可作为其他难以制备的空间拥挤 1,2-氨基醇的直接且有力的入口路线。给出了观察结果的合理机械原理，并将反应应用于潜在生物活性靶标的合成。
• [EN] SUBSTITUTED BENZAMIDE DERIVATIVES<br/>[FR] DÉRIVÉS DE BENZAMIDE SUBSTITUÉS
  申请人：HOFFMANN LA ROCHE

  公开号：WO2011076678A1

  公开（公告）日：2011-06-30

  The invention relates to compounds of formula I wherein R is hydrogen or lower alkyl; R1 is -(CH2)n-(O)o-heterocycloalkyl or -C(O)-heterocycloalkyl, wherein the heterocycloalkyl group is optionally substituted by lower alkyl, hydroxy, halogen or by -(CH2)p-aryl; n is 0, 1 or 2; o is 0 or 1; p is 0, 1 or 2; R2 is CF3, cycloalkyl, optionally substituted by lower alkoxy or halogen, or is indan-2-yl, or is heterocycloalkyl, optionally substituted by heteroaryl, or is aryl or heteroaryl, wherein the aromatic rings are optionally substituted by one or two substituents, selected from lower alkyl, halogen, heteroaryl, hydroxy, CF3, OCF3, OCH2CF3, OCH2-cycloalkyl, OCH2C(CH2OH)(CH2C1)(CH3), S-lower alkyl, lower alkoxy, CH2-lower alkoxy, lower alkinyl or cyano, or by-C(O)-phenyl, -O-phenyl, -O- CH2-phenyl, phenyl or -CH2-phenyl, and wherein the phenyl rings may optionally be substituted by halogen, -C(O)-lower alkyl, -C(O)OH or -C(O)O-lower alkyl, or the aromatic rings are optionally substituted by heterocycloalkyl, OCH2-oxetan-3-yl or O-tetrahydropyran-4-yl, optionally substituted by lower alkyl; X is a bond, -NR'-, -CH2NH-, -CHR''-, -(CHR'')q-O-, -O-(CHR'')q- or -(CH2)2-; Y is a bond or -CH2- R' is hydrogen or lower alkyl, R'' is hydrogen, lower alkyl, CF3, lower alkoxy, q is 0, 1, 2 or 3; or to a pharmaceutically suitable acid addition salt thereof. It has now been found that the compounds of formula I have a good affinity to the trace amine associated receptors (TAARs), especially for TAAR1. The compounds may be used for the treatment of depression, anxiety disorders, bipolar disorder, attention deficit hyperactivity disorder (ADHD), stress-related disorders, psychotic disorders such as schizophrenia, neurological diseases such as Parkinsons disease, neurodegenerative disorders such as Alzheimers disease, epilepsy, migraine, hypertension, substance abuse and metabolic disorders such as eating disorders, diabetes, diabetic complications, obesity, dyslipidemia, disorders of energy consumption and assimilation, disorders and malfunction of body temperature homeostasis, disorders of sleep and circadian rhythm, and cardiovascular disorders.

  该发明涉及以下式I的化合物，其中R是氢或较低的烷基；R1是-(CH2)n-(O)o-杂环烷基或-C(O)-杂环烷基，其中杂环烷基基团可选择地被较低的烷基，羟基，卤素或-(CH2)p-芳基取代；n为0、1或2；o为0或1；p为0、1或2；R2为CF3，环烷基，可选择地被较低的烷氧基或卤素取代，或为茚-2-基，或为杂环烷基，可选择地被杂芳基取代，或为芳基或杂芳基，其中芳香环可选择地被来自较低的烷基，卤素，杂芳基，羟基，CF3，OCF3，OCH2CF3，OCH2-环烷基，OCH2C(CH2OH)(CH2C1)(CH3)，S-较低的烷基，较低的烷氧基，CH2-较低的烷氧基，较低的炔基或氰基，或-C(O)-苯基，-O-苯基，-O-CH2-苯基，苯基或-CH2-苯基选择的一个或两个取代基取代，其中苯环可选择地被卤素，-C(O)-较低的烷基，-C(O)OH或-C(O)O-较低的烷基取代，或芳香环可选择地被杂环烷基，OCH2-氧杂环戊烷-3-基或O-四氢吡喃-4-基，可选择地被较低的烷基取代；X为键，-NR'-，-CH2NH-，-CHR''-，-(CHR'')q-O-，-O-(CHR'')q-或-(CH2)2-；Y为键或-CH2-；R'为氢或较低的烷基，R''为氢，较低的烷基，CF3，较低的烷氧基，q为0、1、2或3；或其药学上适宜的酸盐。现已发现，该式I的化合物对痕量胺相关受体（TAARs）具有良好的亲和力，特别是对于TAAR1。这些化合物可用于治疗抑郁症，焦虑症，躁郁症，注意力缺陷多动障碍（ADHD），与压力有关的疾病，如精神分裂症，帕金森病等神经疾病，阿尔茨海默病等神经退行性疾病，癫痫，偏头痛，高血压，物质滥用和代谢性疾病，如进食障碍，糖尿病，糖尿病并发症，肥胖症，血脂异常，能量消耗和吸收异常，体温稳态异常，睡眠和昼夜节律异常，以及心血管疾病。